Blog
RSS FeedPosted by Michael Wonder on 04 Sep 2018
Vertex announces reimbursement agreement in Australia for Orkambi (lumacaftor/ivacaftor) for people with cystic fibrosis ages six years and older with two copies of the F508del mutation
3 September 2018 - Approximately 1,300 patients in Australia join the thousands of patients worldwide who already have access to lumacaftor/ivacaftor. ...
Posted by Michael Wonder on 04 Sep 2018
Patient charges for PBS prescriptions: example calculations
4 September 2018 - Example calculations of patient charges for PBS prescriptions are now available. ...
Posted by Michael Wonder on 03 Sep 2018
Reducing the time from PBAC recommendation to PBS listing
4 September 2018 - Should other listing types be in the mix? ...
Posted by Michael Wonder on 03 Sep 2018
Biosimilar awareness initiative – literature review
3 September 2018 - The biosimilar literature review update for the period March 2018 to May 2018 is now available. ...
Posted by Michael Wonder on 03 Sep 2018
Medicare-funded cancer genetic tests: a note of caution
3 September 2018 - Clinicians need appropriate education and support in keeping pace with the genomics revolution. ...
Posted by Michael Wonder on 03 Sep 2018
Clark accused of cronyism over PHARMAC appointment
1 September 2018 - David Clark is faced with allegations of cronyism after appointing former Labour MP Steve Maharey chair ...
Posted by Michael Wonder on 03 Sep 2018
Patients wanting special funding for anti-depressants turned down by PHARMAC
2 September 2018 - Last year, PHARMAC stopped subsidising two brands of anti-depressants, Arrow Venlafaxine and Effexor XR, and replaced them ...
Posted by Michael Wonder on 03 Sep 2018
Agenda for September 5 TC meeting
3 September 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 02 Sep 2018
Eligible cystic fibrosis patients get free access to life-changing drug
2 September 2018 - More than 1200 Australians battling the incurable lung disease cystic fibrosis will be given immediate, free ...
Posted by Michael Wonder on 01 Sep 2018
Rheumatoid arthritis, ADHD drugs added to PBS, prices plunge
31 August 2018 - Around 150,000 Australian children living with ADHD will get a reprieve from today when a life-changing ...
Posted by Michael Wonder on 01 Sep 2018
Schedule of Pharmaceutical Benefits - 1 September 2018 update
1 September 2018 - The September 2018 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Aug 2018
Pharma interactions educate and improve health outcomes
31 August 2018 - Medicines Australia is pleased to announce the release of the fifth biannual innovative medicines industry’s transfer ...
Posted by Michael Wonder on 31 Aug 2018
Medicines Australia welcomes announcement LSDP Expert Panel
31 August 2018 - Medicines Australia welcomes today’s announcement by Minister for Health, the Hon Greg Hunt MP on the ...
Posted by Michael Wonder on 31 Aug 2018
New Zealand Pharmaceutical Schedule - 1 September 2018 update
1 September 2018 - The September 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Aug 2018
Expensive life-prolonging drug not an option for many women
30 August 2018 - Wiki Mulholland has the toughest of balancing acts – between staying alive and draining her family ...